Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis

Idarubicin‐Loaded DEB‐TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score‐matching analysis

Abstract Aims To investigate the efficacy and safety of lenvatinib and idarubicin‐loaded drug‐eluting beads transarterial chemoembolization (IDADEB‐TACE) in primary advanced hepatocellular carcinoma (HCC). Methods This retrospective study included patients with primary advanced HCC who received eith...

Full description

Bibliographic Details
Main Authors: Wenzhe Fan, Bowen Zhu, Shufan Yue, Xinlin Zheng, Xinhua Zou, Fuliang Li, Liangliang Qiao, Yanqin Wu, Miao Xue, Hongyu Wang, Yiyang Tang, Jiaping Li
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Medicine
Subjects:
carcinomas
chemoembolization
hepatocellular
idarubicin
lenvatinib
therapeutic
Online Access:https://doi.org/10.1002/cam4.4937

Internet

https://doi.org/10.1002/cam4.4937

Similar Items